Amgen, Astellas, Jimenez, Doliveux, Lee make the 2013 Scrip Awards shortlist
This article was originally published in Scrip
The shortlist for the 9th Annual Scrip Awards is out, and Scrip would like your feedback on the choices. Navigate to Scrip's LinkedIn page to join the discussion. Scrip will host discussions over the next several weeks on each of the categories.
You may also be interested in...
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.
As part of its response to the coronavirus outbreak, Medicines for Europe has set out a series of policy recommendations that it says could help to mitigate the risks of COVID-19.
The coronavirus COVID-19 outbreak poses a “limited immediate risk” to European production and supplies of off-patent drugs, according to industry association Medicines for Europe. However, if the situation continues for an extended period an “important impact” cannot be ruled out.